111 related articles for article (PubMed ID: 2024913)
1. [Comparative study of the vasodilator properties of linsidomine chlorhydrate versus isosorbide dinitrate by the intracoronary route].
Guy JM; Lamaud M; Duranton B; Gerenton C; Berthaud T; Verneyre H
Ann Cardiol Angeiol (Paris); 1991 Feb; 40(2):103-6. PubMed ID: 2024913
[No Abstract] [Full Text] [Related]
2. Comparative efficacy of the intravenous administration of linsidomine, a direct nitric oxide donor, and isosorbide dinitrate in severe unstable angina. A French multicentre study. French Group of Investigators.
Delonca J; Giraud T; Beaufils P; Dupuis B; Haïat R; Théry C
Eur Heart J; 1997 Aug; 18(8):1300-6. PubMed ID: 9458423
[TBL] [Abstract][Full Text] [Related]
3. [Linsidomine, direct donor of EDRF/NO: a new treatment for unstable angina].
Delonca J; Giraud T; Lennuyeux E; Charansonney O
Arch Mal Coeur Vaiss; 1996 Oct; 89 Spec No 5():19-25. PubMed ID: 8952816
[TBL] [Abstract][Full Text] [Related]
4. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort].
Alimova EV; Martsevich SIu; Kutishenko NP; Metelitsa VI
Ter Arkh; 1997; 69(12):37-40. PubMed ID: 9503532
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
[TBL] [Abstract][Full Text] [Related]
6. [Long-acting isosorbide dinitrate and molsidomin in the treatment of effort angina in patients with arterial hypotension].
Idrisova EM; Kladieva EA; Borovkova NV; Vorob'eva EV; Chernov VI; Karpov RS
Ter Arkh; 2002; 74(6):63-6. PubMed ID: 12136489
[TBL] [Abstract][Full Text] [Related]
7. [Molsidomine and isosorbide dinitrate:/their comparative effectiveness in patients with exertion-induced stenocardia].
Martsevich SIu; Metelitsa VI
Kardiologiia; 1988 Jul; 28(7):68-70. PubMed ID: 3062225
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the effectiveness of sustac and nitrosorbid treatment of exertion-induced angina pectoris].
Mazur NA; Nazarenko VA; Martsevich SIu; Nikolenko SA; Vygodin VA
Ter Arkh; 1981; 53(5):48-52. PubMed ID: 6794169
[No Abstract] [Full Text] [Related]
9. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
Ciopor M; Fischer A; Turina J; Hess OM
Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
[TBL] [Abstract][Full Text] [Related]
10. Significant labeling and dosing changes for isosorbide dinitrate.
Drown DJ
Prog Cardiovasc Nurs; 1997; 12(4):32-3. PubMed ID: 9433732
[No Abstract] [Full Text] [Related]
11. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
[No Abstract] [Full Text] [Related]
12. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
Witchitz S; Kolsky H; Moisson P; Valette H
Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
König FK; Grewe R; Wörz K
Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
[No Abstract] [Full Text] [Related]
15. Is administration of nitrates an offence in suspected cases of angina pectoris?
Singh RB
Indian Heart J; 1998; 50(2):233. PubMed ID: 9622998
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
[TBL] [Abstract][Full Text] [Related]
17. Therapy of angina pectoris with propranolol and long-acting nitrates.
Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA
Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122
[No Abstract] [Full Text] [Related]
18. [Methods o clinical evaluation of therapeutic agents for the treatment of angina pectoris].
Mabuchi G
Nihon Ika Daigaku Zasshi; 1970; 37(5):343-58. PubMed ID: 4923115
[No Abstract] [Full Text] [Related]
19. A kinetodardiographic approach to the evaluation of antianginal drugs.
Slany J; Mösslacher H; Kronik G
Bibl Cardiol; 1976; (35):191-6. PubMed ID: 825098
[No Abstract] [Full Text] [Related]
20. [Use of corvaton in patients with angina pectoris].
Korabel'shchikova NI; Bichko MV; Rishko NV; Maksimov SD
Vrach Delo; 1987 Feb; (2):82-5. PubMed ID: 3577099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
